Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
APYX Apyx Medical Corp
- Stocks
- Healthcare
- NASDAQ: APYX
Price (delayed)
$1.93
Market cap
$72.94M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.55
Enterprise value
$80.85M
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products in the cosmetic and surgical markets. Known for its innovative Helium
Highlights
The EPS rose by 17% since the previous quarter and by 17% year-on-year
APYX's net income is up by 15% since the previous quarter and by 12% year-on-year
The quick ratio has declined by 4.7% year-on-year but it is up by 2% since the previous quarter
APYX's equity is down by 48% year-on-year and by 26% since the previous quarter
Apyx Medical's gross profit has decreased by 10% YoY
Key stats
What are the main financial stats of APYX
Market
Valuations
Earnings
Shares outstanding
37.79M
Market cap
$72.94M
Enterprise value
$80.85M
Price to earnings (P/E)
N/A
Price to book (P/B)
6.94
Price to sales (P/S)
1.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.71
Revenue
$47.29M
Gross profit
$29.08M
Operating income
-$15.28M
Net income
-$20.04M
EBIT
-$13.9M
EBITDA
-$13.22M
Free cash flow
-$13.15M
Per share
Balance sheet
Liquidity
EPS
-$0.55
EPS diluted
-$0.55
Free cash flow per share
-$0.35
Book value per share
$0.28
Revenue per share
$1.25
TBVPS
$1.59
Total assets
$60.16M
Total liabilities
$49.52M
Debt
$38.92M
Equity
$10.51M
Working capital
$42.34M
Debt to equity
3.7
Current ratio
5.45
Quick ratio
4.49
Net debt/EBITDA
-0.6
Margins
Efficiency
Dividend
EBITDA margin
-27.9%
Gross margin
61.5%
Net margin
-42.4%
Operating margin
-32.3%
Return on assets
-31.9%
Return on equity
-158.7%
Return on invested capital
-22.9%
Return on capital employed
-27.4%
Return on sales
-29.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
APYX stock price
How has the Apyx Medical stock price performed over time
Intraday
-14.98%
1 week
12.87%
1 month
25.32%
1 year
37.86%
YTD
22.15%
QTD
40.88%
Financial performance
How have Apyx Medical's revenue and profit performed over time
Revenue
$47.29M
Gross profit
$29.08M
Operating income
-$15.28M
Net income
-$20.04M
Gross margin
61.5%
Net margin
-42.4%
APYX's operating income is up by 27% year-on-year and by 19% since the previous quarter
Apyx Medical's operating margin has increased by 22% YoY and by 18% QoQ
APYX's net income is up by 15% since the previous quarter and by 12% year-on-year
APYX's net margin is up by 13% QoQ and by 6% YoY
Price vs fundamentals
How does APYX's price correlate with its fundamentals
Growth
What is Apyx Medical's growth rate over time
Valuation
What is Apyx Medical stock price valuation
P/E
N/A
P/B
6.94
P/S
1.54
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.71
The EPS rose by 17% since the previous quarter and by 17% year-on-year
The price to book (P/B) is 104% higher than the last 4 quarters average of 4.0 and 90% higher than the 5-year quarterly average of 4.3
APYX's equity is down by 48% year-on-year and by 26% since the previous quarter
The stock's price to sales (P/S) is 81% more than its last 4 quarters average of 1.0 but 60% less than its 5-year quarterly average of 4.5
The revenue has declined by 6% year-on-year
Efficiency
How efficient is Apyx Medical business performance
Apyx Medical's return on equity has shrunk by 103% YoY
The return on invested capital is up by 40% year-on-year and by 19% since the previous quarter
The return on sales rose by 23% year-on-year and by 18% since the previous quarter
The company's return on assets rose by 11% QoQ and by 5% YoY
Dividends
What is APYX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for APYX.
Financial health
How did Apyx Medical financials performed over time
The total assets is 21% more than the total liabilities
The total assets has contracted by 15% YoY and by 7% from the previous quarter
Apyx Medical's current ratio has decreased by 7% YoY but it has increased by 3.6% from the previous quarter
The company's debt to equity has surged by 94% YoY and by 36% QoQ
APYX's equity is down by 48% year-on-year and by 26% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.